Graph of Zyflamend enhanced radiosensitivity in SCC15 cells

Figure 1 Zyflamend inhibits the proliferation and potentiates radiosensitivity in SCC15 Cells （A）Cell viability of SCC15 cells treated with increasing concentrations of Zyflamend (0–1 μl/ml) for 24 h and 48 h, as assessed by MTT assay. (B) Representative images of Giemsa-stained colonies from clonogenic survival assays under different treatment conditions: Control, Zyflamend (0.2 μl/ml) alone, Radiation alone (2, 4, 6, 8 Gy), and Zyflamend + Radiation. (C) Cell survival curves based on clonogenic assays after radiation with or without Zyflamend pretreatment. Curves were fitted using the linear-quadratic model. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.